Jérôme Lacotte

Jérôme Lacotte

Auto-generated profile, based on publicly available information

Jérôme Lacotte

Institut Cardiovasculaire Paris Sud, Hopital Prive jacques Cartier, Massy, France

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2008 in EP Europace
Verified
Journal Article
Open access
PDF file
ASAntonio De Sisti
Antonio De Sisti
JTJoelci Tonet
Joelci Tonet
FGFatima Gueffaf
Fatima Gueffaf
FTFaouzi Touil
Faouzi Touil
JLJean-Francois Leclercq
Jean-Francois Leclercq
RFRobert Frank
Robert Frank
The study aimed at evaluating the long-term effects of transient atrioventricular (AV) block on clinical outcomes during atrioventricular nodal re-entrant tachycardia (AVNRT) cryoablation. In 150 consecutive patients (39 ± 14 years, ineffective anti-arrhythmic drugs 1.9 ± 1.3), slow-pathway cryoablation for AVNRT was performed. A 7 Fr 6 mm-tip cryocatheter was used. After successful cryomapping (−30°C), defined as jump abolition or AV nodal refractory period prolongation, cryoablation (−80°C for 4 min) was applied if no AV block occurred. Atrioventricular nodal re-entrant tachycardia inducibility was checked after 30 min. Acute success (AVNRT non-inducibility) was achieved in 142 patients (95%). Overall, after a follow-up of 18 ± 10 months, 118 of 150 patients (79%) were recurrence-free (including 2 patients for whom the procedure was unsuccessful). Among successful procedures, 116 of 142 (82%) patients were recurrence-free. During cryoablation, inadvertent transient AV block of varying degrees occurred in 34 patients (22.7%), namely, increased PR in 17 patients and a 2nd–3rd AV block in the remaining 17. In 24 patients, AV block occurred at the last effective site (increased PR in 13 patients and a 2nd–3rd AV block in 11). In the study population as a whole, univariate predictors of recurrence in the follow-up were AVNRT inducibility ( P < 0.001), increased PR at the last effective site ( P < 0.001), residual jump ( P < 0.02), and small Koch’s triangle (X-ray distance < 11 mm between the His and coronary sinus ostium catheters; P < 0.02). Atrioventricular nodal re-entrant tachycardia inducibility ( P < 0.03), increased PR ( P < 0.01), and small Koch’s triangle ( P < 0.04) were independently significant. For attempts at the last effective site, 3 groups of patients were compared: 13 patients with increased PR duration (Group A), 11 with a 2nd–3rd AV block (Group B), and 126 without AV block (Group C). Cryo-application time was 277 ± 203 s in Group A, 75 ± 87 s in Group B, and 253 ± 135 s in Group C (A vs. B, P < 0.01; B vs. C, P < 0.001; and C vs. A, P = NS). There was no statistical difference among groups in the atriogram/ventriculogram amplitude ratio at the site of the last attempt, unsuccessful acute procedure, small Koch’s triangle, and residual jump. Actuarial incidence of recurrence-free status at 12 months was 38% in A, 82% in B, and 82% in C (A vs. B, P < 0.05; B vs. C, P = NS; and C vs. A, P < 0.001). All AV blocks occurring during cryoablation were transient, confirming the safety of this method. An increased PR duration at the last effective site is associated with a higher recurrence rate, whereas a 2nd–3rd degree AV block has a recurrence rate similar to that of patients without AV block despite a shorter cryo-application time at the last site.

7 April 2007 in EP Europace
Verified
Journal Article
Open access
PDF file
ASA. De Sisti
A. De Sisti
JTJ. Tonet
J. Tonet
NBN. Barakett
N. Barakett
JLJ. Lacotte
J. Lacotte
JLJ.F. Leclercq
J.F. Leclercq
RFR. Frank
R. Frank
Aims Within the last several years, transvenous cryo-ablation has become an alternative method to perform ablation of the slow-pathway. This study evaluated the acute and long-term safety and effectiveness of atrio-ventricular nodal re-entrant tachycardia (AVNRT) cryo-ablation. Methods and results The first 69 consecutive patients with AVNRT (60 slow–fast, 4 fast–slow, and 5 slow–slow) who underwent slow-pathway cryo-ablation were included. Mean age was 37 ± 15, body weight 68 ± 14 kg, symptom duration 125 ± 104 months, and number of ineffective antiarrhythmic (AA) drugs 1.8 ± 1.4. A 7 Fr cryo-catheter (Cryocath®) was used, with initially 4-mm-tip and later with 6-mm-tip electrode. Cryo-mapping (n = 7.9 ± 8.4 per pt) was performed at the temperature of −30°C to test the effect on the target ablation site. Successful cryo-mapping was defined as abolition of nodal conduction jump or AV nodal refractory period prolongation. Cryo-ablation (n = 5.1 ± 4.9 per pt) was then applied by freezing to −75°C for 4 min in duration if no AV-block occurred. Acute procedural success (defined as AVNRT non-inducibility) after the first cryo-ablation attempt was achieved in 60/69 patients (87%). During cryo-ablation, inadvertent transient AV-block was encountered in 14 patients (five I AV-block and nine II–III AV-block). A mid-septal target site was the only variable correlated with inadvertent AV-block occurrence during cryo-ablation (P < 0.02). Long-term clinical success after cryo-ablation was globally achieved in 56/66 (85%) with a mean follow-up of 18 ± 9 months (3 pts dropped-out). After the first procedure, 41/66 (62%) had no relapse, eight had a dramatic reduction in AVNRT duration-frequency and considered themselves cured, and five needed previously ineffective AA (with no relapse in three, drastic reduction in AVNRT duration-frequency in two). The five last patients needed one or more procedures, after which one had no recurrence and one had reduction in duration-frequency. Absence of recurrence after the first procedure was positively correlated with 6-mm-tip cryo-catheter use (<0.001) and negatively with acute procedural success (<0.001). At multivariate analysis, both were independently significant (<0.04 and <0.008, respectively). Long-term clinical success was correlated only with 6-mm-tip cryo-catheter use (<0.001). Conclusions Slow pathway cryo-ablation is associated with an acute success but a higher recurrence rate. A 6-mm-tip cryo-catheter seems to assure during cryo-ablation a large acute and long-term success. AV-block seems non-guaranteed by a negative cryo-mapping, stressing on need of a careful surveillance. Nevertheless, the theoretical advantage of avoiding the risk of permanent AV-block when compared with radiofrequency needs larger series to be demonstrated.

1 April 2014 in Heart Rhythm
Verified
Journal Article
Closed access
JJJulien Seitz Julien
Julien Seitz Julien
JHJérôme Horvilleur
Jérôme Horvilleur
LCLaurence Curel
Laurence Curel
JLJérôme Lacotte
Jérôme Lacotte
AMAlexandre Maluski
Alexandre Maluski
APAndré Pisapia
André Pisapia

9 June 2011 in Pacing and Clinical Electrophysiology
Verified
Journal Article
Closed access
PDF file
JJJulien Seitz Julien
Julien Seitz Julien
JHJérôme Horvilleur
Jérôme Horvilleur
JLJérôme Lacotte
Jérôme Lacotte
DHDarach O H‐Ici
Darach O H‐Ici
YMYamina Mouhoub
Yamina Mouhoub
GJGarot Jérôme
Garot Jérôme

13 December 2007 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
PDF file
ABAimé Bonny
Aimé Bonny
JTJoelci Tonet
Joelci Tonet
GFGuy Fontaine
Guy Fontaine
JLJérôme Lacotte
Jérôme Lacotte
ECElisabeth Coignard
Elisabeth Coignard
RFRobert Frank
Robert Frank

22 December 2009 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
PDF file
CGCaroline Grimard
Caroline Grimard
JLJérôme Lacotte
Jérôme Lacotte
FHFrançoise Hidden‐Lucet
Françoise Hidden‐Lucet
GDGuillaume Duthoit
Guillaume Duthoit
YGYves Gallais
Yves Gallais
RFRobert Frank
Robert Frank